Tags

Type your tag names separated by a space and hit enter

Covid-19: Hydroxychloroquine does not benefit hospitalised patients, UK trial finds.
BMJ. 2020 06 08; 369:m2263.BMJ

Authors+Show Affiliations

London, UK.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32513810

Citation

Torjesen, Ingrid. "Covid-19: Hydroxychloroquine Does Not Benefit Hospitalised Patients, UK Trial Finds." BMJ (Clinical Research Ed.), vol. 369, 2020, pp. m2263.
Torjesen I. Covid-19: Hydroxychloroquine does not benefit hospitalised patients, UK trial finds. BMJ. 2020;369:m2263.
Torjesen, I. (2020). Covid-19: Hydroxychloroquine does not benefit hospitalised patients, UK trial finds. BMJ (Clinical Research Ed.), 369, m2263. https://doi.org/10.1136/bmj.m2263
Torjesen I. Covid-19: Hydroxychloroquine Does Not Benefit Hospitalised Patients, UK Trial Finds. BMJ. 2020 06 8;369:m2263. PubMed PMID: 32513810.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Covid-19: Hydroxychloroquine does not benefit hospitalised patients, UK trial finds. A1 - Torjesen,Ingrid, Y1 - 2020/06/08/ PY - 2020/6/10/entrez PY - 2020/6/10/pubmed PY - 2020/6/10/medline SP - m2263 EP - m2263 JF - BMJ (Clinical research ed.) JO - BMJ VL - 369 SN - 1756-1833 UR - https://www.unboundmedicine.com/medline/citation/32513810/full_citation L2 - http://www.bmj.com/cgi/pmidlookup?view=long&pmid=32513810 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.